First Manhattan
ARRY

First Manhattan’s Array Biopharma Inc ARRY Stock Holding History

First Manhattan’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-1,099,801
Closed -$4.64M – 1480
2015
Q4 		$4.64M Sell
1,099,801
-96,699
-8% -$441K 0.03% 246
2015
Q3 		$5.46M Sell
1,196,500
-385,000
-24% -$2.28M 0.04% 221
2015
Q2 		$11.4M Sell
1,581,500
-38,500
-2% -$284K 0.07% 163
2015
Q1 		$11.9M Buy
1,620,000
+320,000
+25% +$2.28M 0.07% 160
2014
Q4 		$6.15M Buy
+1,300,000
New +$5.14M 0.03% 229
2013
Q4 		– Sell
-65,000
Closed -$404K – 1436
2013
Q3 		$404K Hold
65,000
– – ﹤0.01% 533
2013
Q2 		$406K Buy
+65,000
New +$350K ﹤0.01% 536

Other funds holding ARRY

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return